OMRF Multiple Sclerosis Center of Excellence — Oklahoma City, Oklahoma

OMRF Multiple Sclerosis Center of Excellence is a clinical research site located in Oklahoma City, Oklahoma, United States.

Crixeo Clinical Trials Trust Score: 15/100 (FAILING). This profile has not yet been claimed by the site owner.

OMRF Multiple Sclerosis Center of Excellence has participated in 5 clinical trials with 1 currently active.

Therapeutic areas: Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting.

Sponsors: Acorda Therapeutics, Zenas BioPharma (USA), LLC, Genzyme, a Sanofi Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Oklahoma City

Browse all research sites in Oklahoma · View every site in Oklahoma City

Sponsor Feasibility Report

Trust Score: 15/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for OMRF Multiple Sclerosis Center of Excellence?

OMRF Multiple Sclerosis Center of Excellence has a Crixeo Trust Score of 15/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has OMRF Multiple Sclerosis Center of Excellence conducted?

OMRF Multiple Sclerosis Center of Excellence has 5 clinical trials on record, with 1 currently active. Their work covers Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting.

Is OMRF Multiple Sclerosis Center of Excellence accredited by Crixeo Clinical Trials?

OMRF Multiple Sclerosis Center of Excellence has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about OMRF Multiple Sclerosis Center of Excellence?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.